Catalyst Biosciences Inc
NASDAQ:CBIO
| Market Cap (Intraday) | 128.28M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.47 |
| 50-Day MA | $5.14 |
| 200-Day MA | $5.55 |
Catalyst Biosciences Inc Stock, NASDAQ:CBIO
611 Gateway Boulevard, Suite 710, South San Francisco, California 94080
Phone: +1.650.871.0761
Number of Employees: 56
Description
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.